Search research articles
Contact Us
Filters
Showing results (1-10 of 574) with videos related to
Page
of 58
Sort By:
Current Topics in Behavioral Neurosciences
|
July 14, 2016
Are Non-steroidal Anti-Inflammatory Drugs Clinically Suitable for the Treatment of Symptoms in Depression-Associated Inflammation?
Bernhard T Baune
Current Medical Research and Opinion
|
November 24, 2023
Aripiprazole 2-month ready-to-use 960 mg (Ari 2MRTU): review of its possible role in schizophrenia therapy
Bernhard T Baune
Neuropsychiatric Disease and Treatment
|
April 2, 2009
New developments in the management of major depressive disorder and generalized anxiety disorder: role of quetiapine
Bernhard T Baune
Current Opinion in Psychiatry
|
January 21, 2015
Inflammation and neurodegenerative disorders: is there still hope for therapeutic intervention?
Bernhard T Baune
Pharmacogenomics
|
June 16, 2026
Pharmacogenomics for stratified antidepressant treatment in major depressive disorder: evidence, limits and a roadmap for clinical use
Bernhard T Baune
The Australian and New Zealand Journal of Psychiatry
|
March 28, 2017
Does training of cognitive functions help affective remediation?
Bernhard T Baune
Stroke
|
January 10, 2009
The puzzle of predicting the impact of brain infarcts on cognitive impairment in the aging brain
Bernhard T Baune
The Australian and New Zealand Journal of Psychiatry
|
April 19, 2017
Taking a look into the future: Do clinical and neurobiological trajectories tell us more than what we already know?
Bernhard T Baune
Journal of Clinical Psychopharmacology
|
August 9, 2021
Combination of Tranylcypromine and Mirtazapine in Difficult-to-Treat Depression
Erhan Kavakbasi, Bernhard T Baune
Psychoneuroendocrinology
|
April 25, 2012
Neuroplastic changes in depression: a role for the immune system
Harris Eyre, Bernhard T Baune
Page
of 58
Search research articles
Search
Showing results (1-10 of 574) with videos related to
Sort By:
Page
of 58
Current Topics in Behavioral Neurosciences
|
July 14, 2016
Are Non-steroidal Anti-Inflammatory Drugs Clinically Suitable for the Treatment of Symptoms in Depression-Associated Inflammation?
Bernhard T Baune
Current Medical Research and Opinion
|
November 24, 2023
Aripiprazole 2-month ready-to-use 960 mg (Ari 2MRTU): review of its possible role in schizophrenia therapy
Bernhard T Baune
Neuropsychiatric Disease and Treatment
|
April 2, 2009
New developments in the management of major depressive disorder and generalized anxiety disorder: role of quetiapine
Bernhard T Baune
Current Opinion in Psychiatry
|
January 21, 2015
Inflammation and neurodegenerative disorders: is there still hope for therapeutic intervention?
Bernhard T Baune
Pharmacogenomics
|
June 16, 2026
Pharmacogenomics for stratified antidepressant treatment in major depressive disorder: evidence, limits and a roadmap for clinical use
Bernhard T Baune
The Australian and New Zealand Journal of Psychiatry
|
March 28, 2017
Does training of cognitive functions help affective remediation?
Bernhard T Baune
Stroke
|
January 10, 2009
The puzzle of predicting the impact of brain infarcts on cognitive impairment in the aging brain
Bernhard T Baune
The Australian and New Zealand Journal of Psychiatry
|
April 19, 2017
Taking a look into the future: Do clinical and neurobiological trajectories tell us more than what we already know?
Bernhard T Baune
Journal of Clinical Psychopharmacology
|
August 9, 2021
Combination of Tranylcypromine and Mirtazapine in Difficult-to-Treat Depression
Erhan Kavakbasi, Bernhard T Baune
Psychoneuroendocrinology
|
April 25, 2012
Neuroplastic changes in depression: a role for the immune system
Harris Eyre, Bernhard T Baune
Page
of 58